Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EF-Hand Domain Family, Member D2 (EFHD2) (N-Term) Peptide

EFHD2 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN976165

Aperçu rapide pour EF-Hand Domain Family, Member D2 (EFHD2) (N-Term) Peptide (ABIN976165)

Antigène

EFHD2 (EF-Hand Domain Family, Member D2 (EFHD2))

Origine

Humain

Source

  • 3
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-EFHD2 antibody (Catalog #: ARP58617_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    EFHD2 (EF-Hand Domain Family, Member D2 (EFHD2))

    Sujet

    EFHD2 may regulate B-cell receptor (BCR)-induced immature and primary B-cell apoptosis. It plays a role as negative regulator of the canonical NF-kappa-B-activating branch. EFHD2 controls spontaneous apoptosis through the regulation of BCL2L1 abundance.

    Alias Symbols: MGC4342, RP3-467K16.3, SWS1

    Protein Size: 240

    Poids moléculaire

    26 kDa

    ID gène

    79180

    NCBI Accession

    NM_024329, NP_077305

    UniProt

    Q96C19
Vous êtes ici:
Chat with us!